Incidence and prevalence of pediatric onset multiple sclerosis in Kuwait: 1994-2013

Affiliations

01 January 2015

-

doi: 10.1016/j.jns.2015.04.025


Abstract

Objectives: This study aimed to assess the incidence and prevalence of pediatric-onset multiple sclerosis (POMS) along with temporal and gender differentials in these estimates in Kuwait.

Methods: We identified MS patients with pediatric (age <18 years) onset between 1994 and 2013 from national MS registry. Year and gender-specific incidence rate and prevalence estimates were computed. Multivariable Poisson regression analyses of time-series cross-sectional panel data were conducted to evaluate temporal and gender related variations in yearly POMS incidence rate and prevalence.

Results: 122 POMS patients were identified; of which 90 (73.8%) were females. During 2013, POMS incidence rate and prevalence (per 100,000) were 2.1 and 6.0 respectively. Multivariable Poisson regression model revealed statistically significant 5% increase in POMS incidence rate (p=0.002) and 6% increase in prevalence (p<0.001) from 1994 to 2013. Furthermore, during the study period, female children were more likely to have higher POMS incidence rate (relative rate=2.9; p<0.001) and prevalence (prevalence ratio=2.8; p<0.001).

Conclusions: The temporal increase and gender disparity in POMS incidence and prevalence corroborate the findings of earlier studies conducted elsewhere. Knowledge of increasing POMS burden may help in optimal planning for better management of patients in the region.

Keywords: Incidence; Kuwait; Multiple sclerosis; Pediatric; Prevalence.


Similar articles

Age-Period-Cohort Modeling of Multiple Sclerosis Incidence Rates in Kuwait: 1980-2014.

Akhtar S, Al-Abkal J, Al-Hashel JY, Alroughani R.Neuroepidemiology. 2017;49(3-4):152-159. doi: 10.1159/000484318. Epub 2017 Nov 21.PMID: 29161697

Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.

Akhtar S, Alroughani R, Ahmed SF, Al-Hashel JY.Mult Scler. 2016 Jul;22(8):1086-93. doi: 10.1177/1352458515608960. Epub 2015 Oct 9.PMID: 26453683

Joinpoint Regression Analysis of Trends in Multiple Sclerosis Incidence in Kuwait: 1980-2019.

Akhtar S, Al-Abkal J, Alroughani R.Neuroepidemiology. 2020;54(6):472-481. doi: 10.1159/000511205. Epub 2020 Nov 11.PMID: 33176327

Pediatric onset multiple sclerosis.

Deiva K.Rev Neurol (Paris). 2020 Jan-Feb;176(1-2):30-36. doi: 10.1016/j.neurol.2019.02.002. Epub 2019 May 12.PMID: 31088692 Review.

Update on pediatric-onset multiple sclerosis.

Ruet A.Rev Neurol (Paris). 2018 Jun;174(6):398-407. doi: 10.1016/j.neurol.2018.04.003. Epub 2018 May 19.PMID: 29784250 Review.


Cited by

The Clinical and Epidemiological Profile of Paediatric-Onset Multiple Sclerosis in Poland.

Brola W, Steinborn B, Żak M, Mazurkiewicz-Bełdzińska M, Jóźwiak S, Sobolewski P, Wilski M, Bilska M, Siedlarska M, Puzio-Bochen I, Wencel-Warot A, Lemka M, Kroczka S, Czyżyk E, Bocheńska M, Emich-Widera E, Pietruszewski J, Boćkowski L, Kapica-Topczewska K, Czarnowska A, Kułakowska A, Ujma-Czapska B, Gruna-Ożarowska A, Przysło Ł, Połatyńska K, Dudzińska M, Mitosek-Szewczyk K, Melnyk A, Adamczyk-Sowa M, Kotulska K.J Clin Med. 2022 Dec 17;11(24):7494. doi: 10.3390/jcm11247494.PMID: 36556109 Free PMC article.

Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia.

Bunyan R, Al Towaijri G, Al Otaibi H, Kareem A, Algahtani H, Al Mejally M, Almubarak A, Alrajeh S, Cupler E, Qureshi S, Alawi S, Kalakatawi M, Al Malik Y, Nahrir S, Alhazzani A, El-Metwally A, Shami S, Ishak S, Almudaiheem H, Al-Jedai A, AlJumah M.Mult Scler Int. 2021 Nov 9;2021:4226141. doi: 10.1155/2021/4226141. eCollection 2021.PMID: 34796030 Free PMC article.

Characteristics of pediatric multiple sclerosis: A tertiary referral center study.

Nikolić B, Ivančević N, Zaletel I, Rovčanin B, Samardžić J, Jančić J.PLoS One. 2020 Dec 2;15(12):e0243031. doi: 10.1371/journal.pone.0243031. eCollection 2020.PMID: 33264341 Free PMC article.

Multiple Sclerosis in Children: Current and Emerging Concepts.

Brenton JN, Kammeyer R, Gluck L, Schreiner T, Makhani N.Semin Neurol. 2020 Apr;40(2):192-200. doi: 10.1055/s-0040-1703000. Epub 2020 Apr 15.PMID: 32294785 Free PMC article. Review.

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.

Arnold DL, Banwell B, Bar-Or A, Ghezzi A, Greenberg BM, Waubant E, Giovannoni G, Wolinsky JS, Gärtner J, Rostásy K, Krupp L, Tardieu M, Brück W, Stites TE, Pearce GL, Häring DA, Merschhemke M, Chitnis T; PARADIGMS Study Investigators.J Neurol Neurosurg Psychiatry. 2020 May;91(5):483-492. doi: 10.1136/jnnp-2019-322138. Epub 2020 Mar 4.PMID: 32132224 Free PMC article. Clinical Trial.


KMEL References